Medicxi

cb Email

Status

ACTIVE

Global HQ

London, United Kingdom

Countries of investment

United Kingdom
United States

Investment stages

Series A
Growth

Industries

Biotechnology
Diagnostics
Health Tech
Life Sciences
Medical Devices
Pharma
Precision Medicine
Science

About
Medicxi invests in life sciences companies along the full drug development continuum, from discovery stage to clinical trials, with a mission to bring novel therapies to patients. The firm uses an "asset-centric" investment model and a scientific approach, often forming virtual companies to pursue specific drug candidates and investing significant capital in late-stage growth rounds.

Min check size: $2M
Max check size: $100M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Medicxi invests in life sciences and drug development using an "asset-centric" model. It focuses on bringing novel therapies to market by funding companies from discovery to late-stage clinical trials across Europe and the US, emphasizing significant late-stage growth capital.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The management team comprises seasoned MDs and PhDs with extensive experience in drug discovery, clinical development, and venture capital. Their backgrounds include decades of senior roles in major pharmaceutical companies like GSK and leading biotech firms, leveraging collective experience in bringing novel therapies to market.